Abstract: To assess drug plasma levels, preanesthetic sedation, cardiopulmonary effects during anesthesia and recovery in horses anesthetized with isoflurane combined with medetomidine or xylazine. Prospective blinded randomized clinical study. Sixty horses undergoing elective surgery. Thirty minutes after administration of antibiotics, flunixine meglumine or phenylbutazone and acepromazine horses received medetomidine 7 μg kg (group MED) or xylazine 1.1 mg kg (group XYL) slowly intravenously (IV) and sedation was assessed 3 min later. Anesthesia was induced with ketamine/diazepam and maintained with isoflurane in oxygen/air and medetomidine 3.5 μg kg h or xylazine 0.69 mg kg h. Ringer's acetate 10 mL kg h and dobutamine were administered to maintain normotension. All horses were mechanically ventilated to maintain end-tidal carbon dioxide pressures at 45 ± 5 mmHg (5.3-6.7 kPa). Heart rate (HR), invasive arterial blood pressures, inspired and expired gas compositions, pH, arterial blood gases, electrolytes, lactate and glucose were measured. For recovery all horses received intramuscular morphine 0.1 mg kg and medetomidine 2 μg kg or xylazine 0.3 mg kg IV. Recovery was timed and scored using three different scoring systems. Plasma samples to measure medetomidine and xylazine concentrations were collected at predetermined timepoints. Repeatedly measured parameters were analyzed using a two-way repeated-measures analysis of variance for differences between groups and over time; < 0.05 was considered statistically significant. Mean arterial blood pressures (MAP) stayed within normal ranges but were higher ( = 0.011) in group XYL despite significant lower dobutamine doses ( = 0.0003). Other measured parameters were within clinically acceptable ranges. Plasma levels were at steady state during anesthesia (MED 2.194 ± 0.073; XYL 708 ± 18.791 ng mL). During recovery lateral recumbency (MED 42.7 ± 2.51; XYL 34.3 ± 2.63 min; = 0.027) and time to standing (MED 62.0 ± 2.86; XYL 48.8 ± 3.01 min; = 0.002) were significantly shorter in group XYL compared to group MED. Recovery scores did not differ significantly between groups. In horses anesthetized with isoflurane and medetomidine or xylazine, xylazine maintained higher MAP, reduced the dobutamine consumption and recovery time, whilst overall recovery quality was unaffected.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The study looks into a comparison of effects between two drugs, Medetomidine and Xylazine, when used in combination with Isoflurane for anesthesia during horse surgery. It mainly focuses on the effects of the two drugs on sedation, cardiopulmonary actions, and recovery in horses.
Study Design
The research is a prospective blinded randomized clinical study, involving 60 horses that were set to undergo elective surgery.
Both drugs were applied intravenously, 30 minutes after the administration of antibiotics, flunixine meglumine or phenylbutazone and acepromazine, and sedation was observed 3 min later.
Anesthesia was induced with ketamine/diazepam and maintained with isoflurane in oxygen/air and either medetomidine or xylazine. To maintain normotension, Ringer’s acetate and dobutamine were applied.
All horses were mechanically ventilated to maintain end-tidal carbon dioxide pressures at optimal levels. Different parameters were measured including heart rate, arterial blood pressures, pH, electrolytes, lactate and glucose among others.
During recovery, all horses received intramuscular morphine and either medetomidine or xylazine. Recovery was timed and scored using three different scoring systems.
Plasma samples were collected at predetermined timepoints to measure the concentrations of medetomidine and xylazine.
Results
Mean arterial blood pressures remained in normal ranges but were higher in the xylazine group even though they received significantly lower dobutamine doses.
All other parameters were in the clinically acceptable ranges.
During anesthesia, plasma levels were steady for both groups.
Different measures of recovery time including lateral recumbency and time to standing were found to be significantly shorter in the xylazine group.
However, recovery scores did not differ significantly between the groups.
Conclusions
The findings suggest that using xylazine with isoflurane for anesthesia in horses provides better results than medetomidine. Xylazine was found to maintain higher mean arterial blood pressures, reduce the consumption of dobutamine and shorten recovery time.
However, the overall recovery quality, judged by recovery scores, was similar in both groups.
Cite This Article
APA
Wiederkehr A, Barbarossa A, Ringer SK, Jörger FB, Bryner M, Bettschart-Wolfensberger R.
(2021).
Clinical Randomized Comparison of Medetomidine and Xylazine for Isoflurane Balanced Anesthesia in Horses.
Front Vet Sci, 8, 603695.
https://doi.org/10.3389/fvets.2021.603695
Section Anesthesiology, Department of Clinical Diagnostics and Services, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Barbarossa, Andrea
Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Ringer, Simone K
Section Anesthesiology, Department of Clinical Diagnostics and Services, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Jörger, Fabiola B
Section Anesthesiology, Department of Clinical Diagnostics and Services, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Bryner, Marco
Clinic for Equine Surgery, Equine Department, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Bettschart-Wolfensberger, Regula
Section Anesthesiology, Department of Clinical Diagnostics and Services, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Virtanen R, Savola JM, Saano V, Nyman L. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist.. Eur J Pharmacol 1988 May 20;150(1-2):9-14.
Bettschart-Wolfensberger R, Bettschart RW, Vainio O, Marlin D, Clarke KW. Cardiopulmonary effects of a two hour medetomidine infusion and its antagonism by atipamezole in horses and ponies. J Vet Anaesth (1999) 26:8–12.
Chang LJ, Wang Z, Lien CY, Wen AHC. Comparison of anesthetic effects of xylazine combined with alfaxalone or ketamine and maintained with isoflurane in captive Formosan Reeve's Muntjac (Muntiacus reevesi micrurus). Ir Vet J 2025 Feb 8;78(1):6.
Sancak T. The effects of repeated doses of xylazine-ketamine and medetomidineketamine anesthesia on DNA damage in the liver and kidney. Acta Cir Bras 2023;38:e385723.